"sample_name"	"alt_sample_name"	"unique_patient_ID"	"sample_type"	"surgery_type"	"histological_type"	"summarygrade"	"summarystage"	"T"	"substage"	"G"	"N"	"M"	"visceral_metastasis"	"lymphovascular_invasion"	"age"	"gender"	"ecog_ps"	"neoadjuvant_chemo"	"neoadjuvant_regimen"	"adjuvant_chemo"	"adjuvant_regimen"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"dfs_event"	"smoking_status"	"smoking_package_years"	"nomogram_score"	"batch"	"uncurated_author_metadata"
"GSM340537"	"Control C010"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C010///geo_accession: GSM340537///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340538"	"Control C017"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C017///geo_accession: GSM340538///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340539"	"Control C029"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C029///geo_accession: GSM340539///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340540"	"Control C030"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C030///geo_accession: GSM340540///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340541"	"Control C040"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C040///geo_accession: GSM340541///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340542"	"Control C041"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C041///geo_accession: GSM340542///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340543"	"Control C044"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C044///geo_accession: GSM340543///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340544"	"Control C045"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C045///geo_accession: GSM340544///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340545"	"Control C051"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C051///geo_accession: GSM340545///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340546"	"Control C072"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Control C072///geo_accession: GSM340546///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Normal bladder mucosae///organism_ch1: Homo sapiens///characteristics_ch1: biological source: normal bladder mucosae///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340547"	"Surrounding BS017"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS017///geo_accession: GSM340547///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340548"	"Surrounding BS038"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS038///geo_accession: GSM340548///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340549"	"Surrounding BS039"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS039///geo_accession: GSM340549///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340550"	"Surrounding BS040"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS040///geo_accession: GSM340550///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340551"	"Surrounding BS041"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS041///geo_accession: GSM340551///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340552"	"Surrounding BS044"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS044///geo_accession: GSM340552///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340553"	"Surrounding BS045"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS045///geo_accession: GSM340553///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340554"	"Surrounding BS047"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS047///geo_accession: GSM340554///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340555"	"Surrounding BS048"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS048///geo_accession: GSM340555///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340556"	"Surrounding BS051"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS051///geo_accession: GSM340556///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340557"	"Surrounding BS052"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS052///geo_accession: GSM340557///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340558"	"Surrounding BS054"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS054///geo_accession: GSM340558///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340559"	"Surrounding BS059"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS059///geo_accession: GSM340559///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340560"	"Surrounding BS063"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS063///geo_accession: GSM340560///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340561"	"Surrounding BS065"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS065///geo_accession: GSM340561///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340562"	"Surrounding BS068"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS068///geo_accession: GSM340562///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340563"	"Surrounding BS073"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS073///geo_accession: GSM340563///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340564"	"Surrounding BS075"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS075///geo_accession: GSM340564///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340565"	"Surrounding BS080"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS080///geo_accession: GSM340565///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340566"	"Surrounding BS081"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS081///geo_accession: GSM340566///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340567"	"Surrounding BS083"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS083///geo_accession: GSM340567///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340568"	"Surrounding BS084"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS084///geo_accession: GSM340568///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340569"	"Surrounding BS085"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS085///geo_accession: GSM340569///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340570"	"Surrounding BS086"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS086///geo_accession: GSM340570///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340571"	"Surrounding BS087"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS087///geo_accession: GSM340571///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340572"	"Surrounding BS089"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS089///geo_accession: GSM340572///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340573"	"Surrounding BS091"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS091///geo_accession: GSM340573///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340574"	"Surrounding BS093"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS093///geo_accession: GSM340574///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340575"	"Surrounding BS095"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS095///geo_accession: GSM340575///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340576"	"Surrounding BS097"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS097///geo_accession: GSM340576///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340577"	"Surrounding BS100"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS100///geo_accession: GSM340577///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340578"	"Surrounding BS101"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS101///geo_accession: GSM340578///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340579"	"Surrounding BS104"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS104///geo_accession: GSM340579///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340580"	"Surrounding BS106"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS106///geo_accession: GSM340580///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340581"	"Surrounding BS107"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS107///geo_accession: GSM340581///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340582"	"Surrounding BS108"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS108///geo_accession: GSM340582///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340583"	"Surrounding BS109"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS109///geo_accession: GSM340583///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340584"	"Surrounding BS111"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS111///geo_accession: GSM340584///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340585"	"Surrounding BS113"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS113///geo_accession: GSM340585///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340586"	"Surrounding BS115"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS115///geo_accession: GSM340586///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340587"	"Surrounding BS117"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS117///geo_accession: GSM340587///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340588"	"Surrounding BS119"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS119///geo_accession: GSM340588///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340589"	"Surrounding BS123"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS123///geo_accession: GSM340589///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340590"	"Surrounding BS125"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS125///geo_accession: GSM340590///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340591"	"Surrounding BS126"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS126///geo_accession: GSM340591///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340592"	"Surrounding BS129"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS129///geo_accession: GSM340592///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340593"	"Surrounding BS130"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS130///geo_accession: GSM340593///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340594"	"Surrounding BS131"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS131///geo_accession: GSM340594///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340595"	"Surrounding BS134"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS134///geo_accession: GSM340595///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340596"	"Surrounding BS135"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS135///geo_accession: GSM340596///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340597"	"Surrounding BS142"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS142///geo_accession: GSM340597///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340598"	"Surrounding BS150"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS150///geo_accession: GSM340598///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340599"	"Surrounding BS168"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS168///geo_accession: GSM340599///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340600"	"Surrounding BS169"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS169///geo_accession: GSM340600///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340601"	"Surrounding BS170"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS170///geo_accession: GSM340601///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340602"	"Surrounding BS301"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS301///geo_accession: GSM340602///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340603"	"Surrounding BS302"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS302///geo_accession: GSM340603///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340604"	"Surrounding BS303"	NA	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Surrounding BS303///geo_accession: GSM340604///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Bladder mucosae surrounding cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: bladder mucosae surrounding cancer///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340605"	"Primary bladder cancer BT001"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	78	"m"	NA	NA	NA	"n"	NA	NA	NA	553	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT001///geo_accession: GSM340605///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 78///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 18.17///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340606"	"Primary bladder cancer BT002"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	54	"f"	NA	NA	NA	"n"	NA	NA	NA	4169	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT002///geo_accession: GSM340606///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 54///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 136.97///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340607"	"Primary bladder cancer BT003"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	37	"m"	NA	NA	NA	"n"	NA	NA	NA	4151	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT003///geo_accession: GSM340607///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 37///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 136.37///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340608"	"Primary bladder cancer BT004"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	72	"m"	NA	NA	NA	"n"	NA	NA	NA	819	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT004///geo_accession: GSM340608///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 26.9///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340609"	"Primary bladder cancer BT005"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"m"	NA	NA	NA	"n"	NA	NA	NA	2650	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT005///geo_accession: GSM340609///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 87.07///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340610"	"Primary bladder cancer BT006"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	80	"m"	NA	NA	NA	"n"	NA	NA	NA	466	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT006///geo_accession: GSM340610///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 15.3///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340611"	"Primary bladder cancer BT007"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	564	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT007///geo_accession: GSM340611///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: death///characteristics_ch1.12: survival month: 18.53///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340612"	"Primary bladder cancer BT008"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	58	"m"	NA	NA	NA	"y"	NA	NA	NA	3955	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT008///geo_accession: GSM340612///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 58///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 129.93///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340613"	"Primary bladder cancer BT009"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	77	"f"	NA	NA	NA	"n"	NA	NA	NA	383	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT009///geo_accession: GSM340613///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 77///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 12.57///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340614"	"Primary bladder cancer BT010"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	64	"m"	NA	NA	NA	"y"	NA	NA	NA	3926	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT010///geo_accession: GSM340614///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3aN0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 128.97///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340615"	"Primary bladder cancer BT011"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	3806	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT011///geo_accession: GSM340615///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 125.03///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340616"	"Primary bladder cancer BT012"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	56	"f"	NA	NA	NA	"n"	NA	NA	NA	3813	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT012///geo_accession: GSM340616///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 56///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 125.27///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340617"	"Primary bladder cancer BT013"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	69	"m"	NA	NA	NA	"n"	NA	NA	NA	3975	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT013///geo_accession: GSM340617///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 69///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 130.6///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340618"	"Primary bladder cancer BT014"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	0	0	NA	NA	75	"m"	NA	NA	NA	"y"	NA	NA	NA	31	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT014///geo_accession: GSM340618///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 75///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 1.03///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340619"	"Primary bladder cancer BT015"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	76	"m"	NA	NA	NA	"n"	NA	NA	NA	3947	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT015///geo_accession: GSM340619///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 76///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 129.67///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340620"	"Primary bladder cancer BT016"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	61	"m"	NA	NA	NA	"y"	NA	NA	NA	507	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT016///geo_accession: GSM340620///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 61///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3aN2M1///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 16.67///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340621"	"Primary bladder cancer BT017"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	45	"m"	NA	NA	NA	"n"	NA	NA	NA	3885	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT017///geo_accession: GSM340621///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 45///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 127.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340622"	"Primary bladder cancer BT018"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	58	"m"	NA	NA	NA	"n"	NA	NA	NA	3790	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT018///geo_accession: GSM340622///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 58///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 124.53///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340623"	"Primary bladder cancer BT019"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	2	0	NA	NA	71	"f"	NA	NA	NA	"n"	NA	NA	NA	95	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT019///geo_accession: GSM340623///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 71///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T4N2M1///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 3.13///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340624"	"Primary bladder cancer BT020"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	2007	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT020///geo_accession: GSM340624///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 65.93///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340625"	"Primary bladder cancer BT021"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	75	"m"	NA	NA	NA	"n"	NA	NA	NA	98	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT021///geo_accession: GSM340625///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 75///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 3.23///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340626"	"Primary bladder cancer BT022"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	3671	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT022///geo_accession: GSM340626///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 120.6///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340627"	"Primary bladder cancer BT023"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"f"	NA	NA	NA	"n"	NA	NA	NA	690	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT023///geo_accession: GSM340627///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 22.67///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340628"	"Primary bladder cancer BT024"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	56	"m"	NA	NA	NA	"y"	NA	NA	NA	3668	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT024///geo_accession: GSM340628///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 56///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3aN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 120.5///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340629"	"Primary bladder cancer BT025"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	82	"m"	NA	NA	NA	"n"	NA	NA	NA	1535	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT025///geo_accession: GSM340629///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 82///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 50.43///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340630"	"Primary bladder cancer BT026"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	38	"m"	NA	NA	NA	"y"	NA	NA	NA	2018	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT026///geo_accession: GSM340630///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 38///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 66.3///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340631"	"Primary bladder cancer BT027"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	55	"m"	NA	NA	NA	"n"	NA	NA	NA	3658	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT027///geo_accession: GSM340631///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 55///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 120.17///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340632"	"Primary bladder cancer BT028"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	53	"m"	NA	NA	NA	"n"	NA	NA	NA	3671	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT028///geo_accession: GSM340632///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 53///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 120.6///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340633"	"Primary bladder cancer BT029"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	64	"m"	NA	NA	NA	"y"	NA	NA	NA	443	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT029///geo_accession: GSM340633///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 14.57///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340634"	"Primary bladder cancer BT030"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	68	"m"	NA	NA	NA	"y"	NA	NA	NA	3526	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT030///geo_accession: GSM340634///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3aN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 115.83///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340635"	"Primary bladder cancer BT031"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	65	"m"	NA	NA	NA	"n"	NA	NA	NA	3245	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT031///geo_accession: GSM340635///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 65///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 106.6///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340636"	"Primary bladder cancer BT032"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	65	"f"	NA	NA	NA	"y"	NA	NA	NA	3689	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT032///geo_accession: GSM340636///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 65///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 121.2///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340637"	"Primary bladder cancer BT033"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	74	"m"	NA	NA	NA	"n"	NA	NA	NA	2983	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT033///geo_accession: GSM340637///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 74///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 98///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340638"	"Primary bladder cancer BT034"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	2040	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT034///geo_accession: GSM340638///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: death///characteristics_ch1.12: survival month: 67.03///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340639"	"Primary bladder cancer BT035"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	61	"m"	NA	NA	NA	"n"	NA	NA	NA	3036	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT035///geo_accession: GSM340639///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 61///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 99.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340640"	"Primary bladder cancer BT036"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	78	"m"	NA	NA	NA	"n"	NA	NA	NA	1531	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT036///geo_accession: GSM340640///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 78///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 50.3///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340641"	"Primary bladder cancer BT037"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	52	"m"	NA	NA	NA	"n"	NA	NA	NA	2990	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT037///geo_accession: GSM340641///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 52///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 98.23///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340642"	"Primary bladder cancer BT038"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	65	"m"	NA	NA	NA	"n"	NA	NA	NA	3227	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT038///geo_accession: GSM340642///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 65///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 106.03///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340643"	"Primary bladder cancer BT039"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	69	"m"	NA	NA	NA	"n"	NA	NA	NA	2901	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT039///geo_accession: GSM340643///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 69///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 95.3///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340644"	"Primary bladder cancer BT040"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	64	"m"	NA	NA	NA	"n"	NA	NA	NA	2448	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT040///geo_accession: GSM340644///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 80.43///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340645"	"Primary bladder cancer BT041"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	69	"m"	NA	NA	NA	"y"	NA	NA	NA	1087	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT041///geo_accession: GSM340645///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 69///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: Yes///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 35.7///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340646"	"Primary bladder cancer BT042"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	75	"f"	NA	NA	NA	"n"	NA	NA	NA	1576	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT042///geo_accession: GSM340646///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 75///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 51.77///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340647"	"Primary bladder cancer BT043"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	53	"m"	NA	NA	NA	"n"	NA	NA	NA	2826	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT043///geo_accession: GSM340647///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 53///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 92.83///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340648"	"Primary bladder cancer BT044"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	58	"m"	NA	NA	NA	"n"	NA	NA	NA	2762	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT044///geo_accession: GSM340648///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 58///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 90.73///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340649"	"Primary bladder cancer BT045"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	35	"m"	NA	NA	NA	"n"	NA	NA	NA	2754	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT045///geo_accession: GSM340649///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 35///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 90.47///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340650"	"Primary bladder cancer BT046"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	43	"m"	NA	NA	NA	"n"	NA	NA	NA	2620	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT046///geo_accession: GSM340650///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 43///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 86.07///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340651"	"Primary bladder cancer BT047"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	4108	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT047///geo_accession: GSM340651///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 134.97///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340652"	"Primary bladder cancer BT048"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	83	"m"	NA	NA	NA	"n"	NA	NA	NA	2007	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT048///geo_accession: GSM340652///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 83///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 65.93///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340653"	"Primary bladder cancer BT049"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	73	"m"	NA	NA	NA	"n"	NA	NA	NA	786	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT049///geo_accession: GSM340653///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 73///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 25.83///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340654"	"Primary bladder cancer BT050"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	51	"m"	NA	NA	NA	"y"	NA	NA	NA	313	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT050///geo_accession: GSM340654///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 51///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3bN2M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 10.27///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340655"	"Primary bladder cancer BT051"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	88	"f"	NA	NA	NA	"n"	NA	NA	NA	2600	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT051///geo_accession: GSM340655///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 88///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 85.43///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340656"	"Primary bladder cancer BT052"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	77	"m"	NA	NA	NA	"n"	NA	NA	NA	96	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT052///geo_accession: GSM340656///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 77///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 3.17///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340657"	"Primary bladder cancer BT053"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	2545	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT053///geo_accession: GSM340657///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 83.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340658"	"Primary bladder cancer BT054"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	2545	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT054///geo_accession: GSM340658///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 83.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340659"	"Primary bladder cancer BT055"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	2159	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT055///geo_accession: GSM340659///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 70.93///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340660"	"Primary bladder cancer BT056"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	62	"m"	NA	NA	NA	"n"	NA	NA	NA	2485	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT056///geo_accession: GSM340660///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 62///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 81.63///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340661"	"Primary bladder cancer BT057"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	2441	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT057///geo_accession: GSM340661///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 80.2///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340662"	"Primary bladder cancer BT058"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	73	"m"	NA	NA	NA	"n"	NA	NA	NA	2399	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT058///geo_accession: GSM340662///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 73///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 78.83///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340663"	"Primary bladder cancer BT059"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	2396	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT059///geo_accession: GSM340663///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 78.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340664"	"Primary bladder cancer BT060"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	59	"m"	NA	NA	NA	"n"	NA	NA	NA	2153	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT060///geo_accession: GSM340664///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 59///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 70.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340665"	"Primary bladder cancer BT061"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	1	1	NA	NA	78	"m"	NA	NA	NA	"n"	NA	NA	NA	265	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT061///geo_accession: GSM340665///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 78///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N1M1///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 8.7///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340666"	"Primary bladder cancer BT062"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	59	"m"	NA	NA	NA	"n"	NA	NA	NA	2293	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT062///geo_accession: GSM340666///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 59///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 75.33///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340667"	"Primary bladder cancer BT063"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	38	"f"	NA	NA	NA	"n"	NA	NA	NA	2304	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT063///geo_accession: GSM340667///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 38///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 75.7///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340668"	"Primary bladder cancer BT064"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	49	"m"	NA	NA	NA	"n"	NA	NA	NA	2287	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT064///geo_accession: GSM340668///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 49///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 75.13///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340669"	"Primary bladder cancer BT065"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	62	"m"	NA	NA	NA	"n"	NA	NA	NA	2287	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT065///geo_accession: GSM340669///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 62///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 75.13///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340670"	"Primary bladder cancer BT066"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	61	"m"	NA	NA	NA	"n"	NA	NA	NA	2258	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT066///geo_accession: GSM340670///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 61///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 74.17///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340671"	"Primary bladder cancer BT067"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	74	"m"	NA	NA	NA	"n"	NA	NA	NA	494	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT067///geo_accession: GSM340671///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 74///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 16.23///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340672"	"Primary bladder cancer BT068"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	72	"m"	NA	NA	NA	"n"	NA	NA	NA	460	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT068///geo_accession: GSM340672///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 15.1///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340673"	"Primary bladder cancer BT069"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	60	"f"	NA	NA	NA	"y"	NA	NA	NA	342	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT069///geo_accession: GSM340673///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 60///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 11.23///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340674"	"Primary bladder cancer BT070"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	60	"m"	NA	NA	NA	"n"	NA	NA	NA	2113	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT070///geo_accession: GSM340674///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 60///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 69.43///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340675"	"Primary bladder cancer BT071"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	82	"m"	NA	NA	NA	"n"	NA	NA	NA	762	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT071///geo_accession: GSM340675///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 82///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 25.03///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340676"	"Primary bladder cancer BT072"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	2041	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT072///geo_accession: GSM340676///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 67.07///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340677"	"Primary bladder cancer BT073"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	64	"m"	NA	NA	NA	"n"	NA	NA	NA	1985	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT073///geo_accession: GSM340677///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 65.23///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340678"	"Primary bladder cancer BT074"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	0	0	NA	NA	73	"m"	NA	NA	NA	"n"	NA	NA	NA	364	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT074///geo_accession: GSM340678///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 73///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T4N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 11.97///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340679"	"Primary bladder cancer BT075"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	1887	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT075///geo_accession: GSM340679///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 62///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340680"	"Primary bladder cancer BT076"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	77	"m"	NA	NA	NA	"n"	NA	NA	NA	1867	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT076///geo_accession: GSM340680///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 77///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 61.33///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340681"	"Primary bladder cancer BT077"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	1854	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT077///geo_accession: GSM340681///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 60.9///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340682"	"Primary bladder cancer BT078"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	1832	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT078///geo_accession: GSM340682///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 60.2///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340683"	"Primary bladder cancer BT079"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	48	"m"	NA	NA	NA	"n"	NA	NA	NA	1814	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT079///geo_accession: GSM340683///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 48///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 59.6///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340684"	"Primary bladder cancer BT080"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	0	0	NA	NA	76	"m"	NA	NA	NA	"y"	NA	NA	NA	317	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT080///geo_accession: GSM340684///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 76///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 10.4///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340685"	"Primary bladder cancer BT081"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	1822	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT081///geo_accession: GSM340685///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 59.87///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340686"	"Primary bladder cancer BT082"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	1796	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT082///geo_accession: GSM340686///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 59///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340687"	"Primary bladder cancer BT083"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"f"	NA	NA	NA	"n"	NA	NA	NA	1788	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT083///geo_accession: GSM340687///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 58.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340688"	"Primary bladder cancer BT084"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	1405	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT084///geo_accession: GSM340688///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 46.17///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340689"	"Primary bladder cancer BT085"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	80	"f"	NA	NA	NA	"n"	NA	NA	NA	1778	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT085///geo_accession: GSM340689///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 58.43///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340690"	"Primary bladder cancer BT086"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"m"	NA	NA	NA	"n"	NA	NA	NA	1768	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT086///geo_accession: GSM340690///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 58.07///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340691"	"Primary bladder cancer BT087"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	32	"f"	NA	NA	NA	"n"	NA	NA	NA	1754	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT087///geo_accession: GSM340691///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 32///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 57.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340692"	"Primary bladder cancer BT088"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	1105	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT088///geo_accession: GSM340692///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 36.3///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340693"	"Primary bladder cancer BT089"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	80	"f"	NA	NA	NA	"n"	NA	NA	NA	1719	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT089///geo_accession: GSM340693///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 56.47///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340694"	"Primary bladder cancer BT090"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	1689	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT090///geo_accession: GSM340694///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 55.5///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340695"	"Primary bladder cancer BT091"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	37	"m"	NA	NA	NA	"n"	NA	NA	NA	1612	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT091///geo_accession: GSM340695///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 37///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 52.97///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340696"	"Primary bladder cancer BT092"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	1	1	NA	NA	71	"m"	NA	NA	NA	"n"	NA	NA	NA	350	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT092///geo_accession: GSM340696///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 71///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N1M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 11.5///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340697"	"Primary bladder cancer BT093"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	0	0	NA	NA	60	"m"	NA	NA	NA	"n"	NA	NA	NA	544	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT093///geo_accession: GSM340697///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 60///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 17.87///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340698"	"Primary bladder cancer BT094"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	74	"m"	NA	NA	NA	"n"	NA	NA	NA	868	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT094///geo_accession: GSM340698///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 74///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 28.53///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340699"	"Primary bladder cancer BT095"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	80	"m"	NA	NA	NA	"n"	NA	NA	NA	537	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT095///geo_accession: GSM340699///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: Yes///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: death///characteristics_ch1.12: survival month: 17.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340700"	"Primary bladder cancer BT096"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	85	"m"	NA	NA	NA	"n"	NA	NA	NA	469	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT096///geo_accession: GSM340700///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 85///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 15.4///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340701"	"Primary bladder cancer BT097"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	59	"f"	NA	NA	NA	"y"	NA	NA	NA	1474	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT097///geo_accession: GSM340701///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 59///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 48.43///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340702"	"Primary bladder cancer BT098"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	1	1	NA	NA	65	"f"	NA	NA	NA	"y"	NA	NA	NA	137	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT098///geo_accession: GSM340702///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 65///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N1M1///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 4.5///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340703"	"Primary bladder cancer BT099"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	57	"m"	NA	NA	NA	"n"	NA	NA	NA	1446	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT099///geo_accession: GSM340703///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 57///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 47.5///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340704"	"Primary bladder cancer BT100"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	1	1	NA	NA	73	"m"	NA	NA	NA	"n"	NA	NA	NA	159	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT100///geo_accession: GSM340704///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 73///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N1M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 5.23///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340705"	"Primary bladder cancer BT101"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	66	"m"	NA	NA	NA	"y"	NA	NA	NA	1388	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT101///geo_accession: GSM340705///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 45.6///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340706"	"Primary bladder cancer BT102"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	1374	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT102///geo_accession: GSM340706///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 45.13///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340707"	"Primary bladder cancer BT103"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	64	"m"	NA	NA	NA	"n"	NA	NA	NA	1324	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT103///geo_accession: GSM340707///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 43.5///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340708"	"Primary bladder cancer BT104"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"m"	NA	NA	NA	"n"	NA	NA	NA	1342	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT104///geo_accession: GSM340708///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 44.1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340709"	"Primary bladder cancer BT105"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	59	"f"	NA	NA	NA	"n"	NA	NA	NA	180	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT105///geo_accession: GSM340709///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 59///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 5.93///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340710"	"Primary bladder cancer BT106"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	960	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT106///geo_accession: GSM340710///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 31.53///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340711"	"Primary bladder cancer BT107"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"f"	NA	NA	NA	"n"	NA	NA	NA	1272	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT107///geo_accession: GSM340711///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 41.8///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340712"	"Primary bladder cancer BT108"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	2	0	NA	NA	79	"m"	NA	NA	NA	"n"	NA	NA	NA	198	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT108///geo_accession: GSM340712///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 79///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N2M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 6.5///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340713"	"Primary bladder cancer BT109"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	44	"m"	NA	NA	NA	"n"	NA	NA	NA	1250	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT109///geo_accession: GSM340713///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 44///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 41.07///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340714"	"Primary bladder cancer BT110"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	NA	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	1210	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT110///geo_accession: GSM340714///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2bN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 39.77///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340715"	"Primary bladder cancer BT111"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	61	"m"	NA	NA	NA	"n"	NA	NA	NA	1186	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT111///geo_accession: GSM340715///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 61///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 38.97///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340716"	"Primary bladder cancer BT113"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	80	"f"	NA	NA	NA	"n"	NA	NA	NA	973	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT113///geo_accession: GSM340716///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 31.97///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340717"	"Primary bladder cancer BT114"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	57	"m"	NA	NA	NA	"n"	NA	NA	NA	1135	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT114///geo_accession: GSM340717///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 57///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 37.3///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340718"	"Primary bladder cancer BT115"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	NA	0	NA	NA	55	"m"	NA	NA	NA	"y"	NA	NA	NA	1121	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT115///geo_accession: GSM340718///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 55///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2aN0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 36.83///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340719"	"Primary bladder cancer BT116"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	52	"m"	NA	NA	NA	"n"	NA	NA	NA	1113	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT116///geo_accession: GSM340719///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 52///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 36.57///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340720"	"Primary bladder cancer BT117"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	NA	0	NA	NA	50	"m"	NA	NA	NA	"n"	NA	NA	NA	855	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT117///geo_accession: GSM340720///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 50///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2aN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 28.1///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340721"	"Primary bladder cancer BT118"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	78	"m"	NA	NA	NA	"n"	NA	NA	NA	120	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT118///geo_accession: GSM340721///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 78///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 3.93///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340722"	"Primary bladder cancer BT119"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	71	"f"	NA	NA	NA	"n"	NA	NA	NA	716	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT119///geo_accession: GSM340722///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 71///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 23.53///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340723"	"Primary bladder cancer BT120"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	0	0	NA	NA	81	"f"	NA	NA	NA	"n"	NA	NA	NA	460	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT120///geo_accession: GSM340723///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 81///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 15.1///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340724"	"Primary bladder cancer BT121"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	43	"m"	NA	NA	NA	"n"	NA	NA	NA	1061	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT121///geo_accession: GSM340724///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 43///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 34.87///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340725"	"Primary bladder cancer BT122"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	1	1	NA	NA	80	"m"	NA	NA	NA	"n"	NA	NA	NA	1042	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT122///geo_accession: GSM340725///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N1M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 34.23///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340726"	"Primary bladder cancer BT123"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	47	"m"	NA	NA	NA	"n"	NA	NA	NA	1026	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT123///geo_accession: GSM340726///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 47///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 33.7///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340727"	"Primary bladder cancer BT124"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	NA	0	NA	NA	71	"m"	NA	NA	NA	"y"	NA	NA	NA	337	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT124///geo_accession: GSM340727///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 71///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4aN0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 11.07///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340728"	"Primary bladder cancer BT125"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	0	0	NA	NA	73	"f"	NA	NA	NA	"n"	NA	NA	NA	176	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT125///geo_accession: GSM340728///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 73///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 5.77///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340729"	"Primary bladder cancer BT126"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	87	"m"	NA	NA	NA	"n"	NA	NA	NA	1007	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT126///geo_accession: GSM340729///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 87///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 33.07///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340730"	"Primary bladder cancer BT127"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	67	"m"	NA	NA	NA	"n"	NA	NA	NA	1000	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT127///geo_accession: GSM340730///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 32.87///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340731"	"Primary bladder cancer BT128"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	82	"m"	NA	NA	NA	"n"	NA	NA	NA	281	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT128///geo_accession: GSM340731///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 82///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 9.23///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340732"	"Primary bladder cancer BT129"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	1	1	NA	NA	78	"f"	NA	NA	NA	"n"	NA	NA	NA	216	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT129///geo_accession: GSM340732///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 78///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T3N1M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 7.1///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340733"	"Primary bladder cancer BT130"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	60	"m"	NA	NA	NA	"n"	NA	NA	NA	521	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT130///geo_accession: GSM340733///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 60///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 17.13///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340734"	"Primary bladder cancer BT131"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	717	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT131///geo_accession: GSM340734///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 23.57///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340735"	"Primary bladder cancer BT132"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	72	"m"	NA	NA	NA	"n"	NA	NA	NA	934	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT132///geo_accession: GSM340735///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 30.7///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340736"	"Primary bladder cancer BT133"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"m"	NA	NA	NA	"n"	NA	NA	NA	916	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT133///geo_accession: GSM340736///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 30.1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340737"	"Primary bladder cancer BT134"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	64	"m"	NA	NA	NA	"n"	NA	NA	NA	905	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT134///geo_accession: GSM340737///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 29.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340738"	"Primary bladder cancer BT135"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	83	"m"	NA	NA	NA	"n"	NA	NA	NA	470	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT135///geo_accession: GSM340738///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 83///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 15.43///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340739"	"Primary bladder cancer BT136"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	894	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT136///geo_accession: GSM340739///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 29.37///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340740"	"Primary bladder cancer BT137"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	68	"m"	NA	NA	NA	"n"	NA	NA	NA	538	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT137///geo_accession: GSM340740///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 68///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 17.67///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340741"	"Primary bladder cancer BT138"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	867	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT138///geo_accession: GSM340741///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 28.47///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340742"	"Primary bladder cancer BT139"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	45	"f"	NA	NA	NA	"n"	NA	NA	NA	727	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT139///geo_accession: GSM340742///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 45///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 23.9///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340743"	"Primary bladder cancer BT140"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	84	"m"	NA	NA	NA	"n"	NA	NA	NA	717	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT140///geo_accession: GSM340743///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 84///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 23.57///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340744"	"Primary bladder cancer BT141"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	72	"m"	NA	NA	NA	"n"	NA	NA	NA	424	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT141///geo_accession: GSM340744///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: death///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 13.93///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340745"	"Primary bladder cancer BT142"	NA	"tumor"	NA	NA	NA	"invasive"	0	NA	NA	3	0	NA	NA	72	"f"	NA	NA	NA	"n"	NA	NA	NA	65	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT142///geo_accession: GSM340745///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:TaN3M1///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 2.13///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340746"	"Primary bladder cancer BT143"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	66	"m"	NA	NA	NA	"n"	NA	NA	NA	678	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT143///geo_accession: GSM340746///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 22.27///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340747"	"Primary bladder cancer BT144"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	0	0	NA	NA	74	"m"	NA	NA	NA	"y"	NA	NA	NA	209	"deceased"	"doc"	NA	NA	NA	NA	"title: Primary bladder cancer BT144///geo_accession: GSM340747///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 74///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N0M1///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 6.87///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340748"	"Primary bladder cancer BT145"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	63	"m"	NA	NA	NA	"n"	NA	NA	NA	634	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT145///geo_accession: GSM340748///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 63///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: Yes///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 20.83///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340749"	"Primary bladder cancer BT146"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	58	"m"	NA	NA	NA	"n"	NA	NA	NA	658	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT146///geo_accession: GSM340749///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 58///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 21.63///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340750"	"Primary bladder cancer BT147"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	70	"m"	NA	NA	NA	"n"	NA	NA	NA	651	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT147///geo_accession: GSM340750///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 70///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 21.4///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340751"	"Primary bladder cancer BT148"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	40	"m"	NA	NA	NA	"n"	NA	NA	NA	1761	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT148///geo_accession: GSM340751///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 40///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 57.87///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340752"	"Primary bladder cancer BT149"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	80	"f"	NA	NA	NA	"n"	NA	NA	NA	646	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT149///geo_accession: GSM340752///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 80///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 21.23///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340753"	"Primary bladder cancer BT150"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	62	"f"	NA	NA	NA	"n"	NA	NA	NA	646	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT150///geo_accession: GSM340753///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 62///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 21.23///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340754"	"Primary bladder cancer BT151"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	24	"m"	NA	NA	NA	"n"	NA	NA	NA	623	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT151///geo_accession: GSM340754///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 24///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 20.47///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340755"	"Primary bladder cancer BT152"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	45	"m"	NA	NA	NA	"n"	NA	NA	NA	621	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT152///geo_accession: GSM340755///status: Public on Mar 26 2010///submission_date: Nov 07 2008///last_update_date: Mar 26 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 45///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: high///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 20.4///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340756"	"Primary bladder cancer BT153"	NA	"tumor"	NA	NA	NA	"superficial"	0	NA	NA	0	0	NA	NA	67	"f"	NA	NA	NA	"n"	NA	NA	NA	578	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT153///geo_accession: GSM340756///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: Yes///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:TaN0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 19///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340757"	"Primary bladder cancer BT154"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	65	"m"	NA	NA	NA	"y"	NA	NA	NA	2414	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT154///geo_accession: GSM340757///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 65///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 79.3///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340758"	"Primary bladder cancer BT155"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	1	1	NA	NA	59	"f"	NA	NA	NA	"y"	NA	NA	NA	471	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT155///geo_accession: GSM340758///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 59///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N1M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 15.47///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340759"	"Primary bladder cancer BT156"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	1	1	NA	NA	64	"m"	NA	NA	NA	"y"	NA	NA	NA	804	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT156///geo_accession: GSM340759///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 64///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N1M1///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 26.43///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340760"	"Primary bladder cancer BT157"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	0	0	NA	NA	70	"m"	NA	NA	NA	"y"	NA	NA	NA	404	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT157///geo_accession: GSM340760///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 70///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 13.27///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340761"	"Primary bladder cancer BT158"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	66	"m"	NA	NA	NA	"y"	NA	NA	NA	195	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT158///geo_accession: GSM340761///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 66///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3NxM0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 6.4///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340762"	"Primary bladder cancer BT159"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	NA	0	NA	NA	77	"m"	NA	NA	NA	"n"	NA	NA	NA	325	"deceased"	"dod"	NA	NA	NA	NA	"title: Primary bladder cancer BT159///geo_accession: GSM340762///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 77///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T4aN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: death///characteristics_ch1.9: cancer specific survival: death///characteristics_ch1.10: survival month: 10.67///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340763"	"Primary bladder cancer BT160"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	2	0	NA	NA	67	"m"	NA	NA	NA	"y"	NA	NA	NA	552	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT160///geo_accession: GSM340763///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 67///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T2N2M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 18.13///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340764"	"Primary bladder cancer BT161"	NA	"tumor"	NA	NA	NA	"invasive"	3	NA	NA	NA	0	NA	NA	51	"m"	NA	NA	NA	"y"	NA	NA	NA	468	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT161///geo_accession: GSM340764///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 51///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T3aN0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 15.37///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340765"	"Primary bladder cancer BT162"	NA	"tumor"	NA	NA	NA	"invasive"	4	NA	NA	2	0	NA	NA	42	"m"	NA	NA	NA	"y"	NA	NA	NA	359	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT162///geo_accession: GSM340765///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 42///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: Yes///characteristics_ch1.5: stage:T4N2M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 11.8///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340766"	"Primary bladder cancer BT163"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	72	"m"	NA	NA	NA	"n"	NA	NA	NA	331	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT163///geo_accession: GSM340766///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 72///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 10.87///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340767"	"Primary bladder cancer BT164"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	0	0	NA	NA	70	"f"	NA	NA	NA	"n"	NA	NA	NA	305	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT164///geo_accession: GSM340767///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: F///characteristics_ch1.2: AGE: 70///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2N0M0///characteristics_ch1.6: grade: low///characteristics_ch1.7: progression: Yes///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 10.03///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340768"	"Primary bladder cancer BT165"	NA	"tumor"	NA	NA	NA	"superficial"	1	NA	NA	0	0	NA	NA	54	"m"	NA	NA	NA	"n"	NA	NA	NA	205	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT165///geo_accession: GSM340768///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 54///characteristics_ch1.3: invasiveness: non-muscle invasive///characteristics_ch1.4: intravesical therapy: No///characteristics_ch1.5: systemic chemo: No///characteristics_ch1.6: stage:T1N0M0///characteristics_ch1.7: grade: low///characteristics_ch1.8: recurrence: No///characteristics_ch1.9: progression: No///characteristics_ch1.10: overall survival: survival///characteristics_ch1.11: cancer specific survival: survival///characteristics_ch1.12: survival month: 6.73///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340769"	"Primary bladder cancer BT166"	NA	"tumor"	NA	NA	NA	"invasive"	2	NA	NA	NA	0	NA	NA	62	"m"	NA	NA	NA	"n"	NA	NA	NA	161	"living"	"ned"	NA	NA	NA	NA	"title: Primary bladder cancer BT166///geo_accession: GSM340769///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Primary bladder cancer///organism_ch1: Homo sapiens///characteristics_ch1: biological source: primary bladder cancer///characteristics_ch1.1: SEX: M///characteristics_ch1.2: AGE: 62///characteristics_ch1.3: invasiveness: muscle invasive///characteristics_ch1.4: systemic chemo: No///characteristics_ch1.5: stage:T2aN0M0///characteristics_ch1.6: grade: high///characteristics_ch1.7: progression: No///characteristics_ch1.8: overall survival: survival///characteristics_ch1.9: cancer specific survival: survival///characteristics_ch1.10: survival month: 5.3///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340770"	"Recurrent bladder tumor BT034.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT034.1///geo_accession: GSM340770///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340771"	"Recurrent bladder tumor BT036.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT036.1///geo_accession: GSM340771///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340772"	"Recurrent bladder tumor BT036.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT036.2///geo_accession: GSM340772///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340773"	"Recurrent bladder tumor BT041.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT041.1///geo_accession: GSM340773///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340774"	"Recurrent bladder tumor BT042.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT042.1///geo_accession: GSM340774///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340775"	"Recurrent bladder tumor BT047.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT047.1///geo_accession: GSM340775///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340776"	"Recurrent bladder tumor BT047.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT047.2///geo_accession: GSM340776///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340777"	"Recurrent bladder tumor BT047.3"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT047.3///geo_accession: GSM340777///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340778"	"Recurrent bladder tumor BT047.4"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT047.4///geo_accession: GSM340778///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340779"	"Recurrent bladder tumor BT053.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT053.1///geo_accession: GSM340779///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340780"	"Recurrent bladder tumor BT057.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT057.2///geo_accession: GSM340780///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340781"	"Recurrent bladder tumor BT060.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT060.1///geo_accession: GSM340781///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340782"	"Recurrent bladder tumor BT060.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT060.2///geo_accession: GSM340782///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340783"	"Recurrent bladder tumor BT062.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT062.1///geo_accession: GSM340783///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340784"	"Recurrent bladder tumor BT062.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT062.2///geo_accession: GSM340784///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340785"	"Recurrent bladder tumor BT063.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT063.1///geo_accession: GSM340785///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340786"	"Recurrent bladder tumor BT067.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT067.1///geo_accession: GSM340786///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340787"	"Recurrent bladder tumor BT067.2"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT067.2///geo_accession: GSM340787///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340788"	"Recurrent bladder tumor BT067.3"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT067.3///geo_accession: GSM340788///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340789"	"Recurrent bladder tumor BT069.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT069.1///geo_accession: GSM340789///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340790"	"Recurrent bladder tumor BT071.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT071.1///geo_accession: GSM340790///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
"GSM340791"	"Recurrent bladder tumor BT083.1"	NA	"metastatic"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Recurrent bladder tumor BT083.1///geo_accession: GSM340791///status: Public on May 06 2010///submission_date: Nov 07 2008///last_update_date: May 06 2010///type: RNA///channel_count: 1///source_name_ch1: Recurrent non-muscle invasive tumor///organism_ch1: Homo sapiens///characteristics_ch1: biological source: recurrent non-muscle invasive tumor///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///characteristics_ch1.6: ///characteristics_ch1.7: ///characteristics_ch1.8: ///characteristics_ch1.9: ///characteristics_ch1.10: ///characteristics_ch1.11: ///characteristics_ch1.12: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from tissues with TRIzol (Life Technologies, NY) reagent according to the manufacturers protocol. RNA quality and integrity were confirmed by electrophoresis on agarose gel stained with ethidium bromide and examined under ultraviolet light.///label_ch1: biotin///label_protocol_ch1: Biotin-labeled cRNA samples for hybridization were prepared according to Illuminas recommended sample labeling procedure: 500 ng of total RNA was used for cDNA synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin-labeled cRNA using the Illumina TotalPrep RNA Amplification kit (Ambion Inc., Austin, TX). cRNA concentrations using RiboGreen were measured (Quant-iTTM RiboGreen RNA assay kit; Invitrogen-Molecular Probes, ON, Canada) by the Victor3 spectrophotometer (PerkinElmer, CT) and cRNA quality was checked on a 1% agarose gel.///taxid_ch1: 9606///hyb_protocol: Labeled, amplified material (1,500 ng per array) was hybridized to a ver. 2 of the Illumina Human-6 BeadChip (48K) according to the Manufacturer's instructions (Illumina, Inc., San Diego, CA). Array signals were developed by Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the BeadChip manual.///scan_protocol: Arrays were scanned with an Illumina Bead array Reader confocal scanner (BeadStation 500GXDW; Illumina, Inc., San Diego, CA) according to the Manufacturer's instructions.///description: To export to gene expression data based on unique gene, we use Sample Gene Profile option of Illumina BeadStudio software.  Therefore, a total of 5553 probe data which have duplicated gene aggregated unique genes from the whole 48701 probes on the Human-6 beadChip ver. 2.///data_processing: Array data processing were performed on Illumina BeadStudio software. We normalized gene expression data using Quantile normalization and log2 transformatoin. To export to a data matrix, Sample Gene Profile option of this software was used.///platform_id: GPL6102///contact_name: Seon-Kyu,,Kim///contact_department: Korean Bioinformation Center///contact_institute: Korea Research Institutue of Bioscience & Biotechnology///contact_address: 111 Gwahangno, Yuseong-gu, Daejeon 305-806, Korea///contact_city: Daejeon ///contact_zip.postal_code: 305-906///contact_country: South Korea///supplementary_file: NONE///data_row_count: 43148"
